These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4344095)

  • 21. [Study of the biology of intratype variants of adenovirus serotypes 1, 2, 3, 4 and 7].
    Selivanov AA; Lysov VV; Rudenko LG; Kovaleva TP; Iurlova TI
    Vestn Akad Med Nauk SSSR; 1970; 25(8):46-51. PubMed ID: 4321748
    [No Abstract]   [Full Text] [Related]  

  • 22. Production of interferon in human diploid cell cultures.
    Zielińska-Jenczylik J; Rzucidlo Z; Sypula A; Blach-Olszewska Z; Kidankiewicz T
    Arch Immunol Ther Exp (Warsz); 1976; 24(5):769-75. PubMed ID: 187142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Varicella zoster virus: interferon production and comparative interferon sensitivity in human cell cultures.
    Armstrong RW; Merigan TC
    J Gen Virol; 1971 Jul; 12(1):53-4. PubMed ID: 4329449
    [No Abstract]   [Full Text] [Related]  

  • 24. Transforming growth factor-beta inhibits the antiviral action of interferons in human embryonic fibroblasts.
    Zielińska-Jenczylik J; Inglot AD; Inglot O; Popik W
    J Interferon Res; 1991 Apr; 11(2):87-9. PubMed ID: 1714487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-mediated inhibition of virus penetration.
    Whitaker-Dowling PA; Wilcox DK; Widnell CC; Youngner JS
    Proc Natl Acad Sci U S A; 1983 Feb; 80(4):1083-6. PubMed ID: 6189119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vesicular Stomatitis Virus Transcription Is Inhibited by TRIM69 in the Interferon-Induced Antiviral State.
    Kueck T; Bloyet LM; Cassella E; Zang T; Schmidt F; Brusic V; Tekes G; Pornillos O; Whelan SPJ; Bieniasz PD
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31578292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The target reaction in the antiviral action of mouse interferon against vesicular stomatitis virus multiplication.
    Hoshino M; Taira H; Hattori S; Kawakita M
    J Biochem; 1987 Mar; 101(3):685-94. PubMed ID: 2439495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Action of interferon in enucleated cells.
    Young CS; Pringle CR; Follett EA
    J Virol; 1975 Feb; 15(2):428-9. PubMed ID: 163365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of interferon on cell and virus growth in transformed human cell lines.
    Fuse TK; Morinaga N
    J Gen Virol; 1976 Oct; 33(1):7-15. PubMed ID: 185329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon treatment suppresses enteric adenovirus infection in a model gastrointestinal cell-culture system.
    Sherwood V; King E; Tötemeyer S; Connerton I; Mellits KH
    J Gen Virol; 2012 Mar; 93(Pt 3):618-623. PubMed ID: 22158877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody neutralization studies of the antiviral activities of human leukocyte interferon on different cells.
    Havell EA
    Arch Virol; 1980; 65(3-4):229-36. PubMed ID: 6158304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon protects neurons in culture infected with vesicular stomatitis and herpes simplex viruses.
    Tsukamoto LF; Price RW
    J Neurol Sci; 1982 Oct; 56(1):115-28. PubMed ID: 6183402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitivity of human cell strains to interferon.
    Siewers CM; John CE; Medearis DN
    Proc Soc Exp Biol Med; 1970 Apr; 133(4):1178-83. PubMed ID: 5462272
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of serum on the antiviral and anticellular activities of mouse interferon.
    Kading VH; Blalock JE; Gifford GE
    Arch Virol; 1978; 56(3):237-42. PubMed ID: 205196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenovirus early region 1A modulation of interferon antiviral activity.
    Anderson KP; Fennie EH
    J Virol; 1987 Mar; 61(3):787-95. PubMed ID: 3027405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulatory and inhibitory effects of adenovirus and SV40 on various virus-cell systems.
    Berman LD; Chany C
    Arch Gesamte Virusforsch; 1970; 30(2):203-16. PubMed ID: 4318579
    [No Abstract]   [Full Text] [Related]  

  • 37. Factors affecting the sensitivity of different viruses to interferon.
    Hallum JV; Thacore HR; Youngner JS
    J Virol; 1970 Aug; 6(2):156-62. PubMed ID: 4322869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon treatment inhibits glycosylation of a viral protein.
    Maheshwari RK; Banerjee DK; Waechter CJ; Olden K; Friedman RM
    Nature; 1980 Oct; 287(5781):454-6. PubMed ID: 6159539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiviral and anticellular activities of human and murine type I and type II interferons in human cells monosomic, disomic, and trisomic for chromosome 21.
    Zhang ZX; De Clercq E; Heremans H; Verhaegen-Lewalle M; Content J
    Proc Soc Exp Biol Med; 1982 May; 170(1):103-11. PubMed ID: 6177006
    [No Abstract]   [Full Text] [Related]  

  • 40. Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents.
    Rubin BY; Gupta SL
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):5928-32. PubMed ID: 6160587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.